drug · protein
patient view →insulin human
Marketedupdated 2mo agoby $MNKD MANNKIND CORP🔗 ChEMBL
Approvedcommunity read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for diabetes mellitus and type 2 diabetes mellitus and 46 investigational indications.
indications
investigational
Type 2 Diabetes
targets
Insulin receptor
all catalysts(14)
approval · 14
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that